The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
This is a curated summary. The full story was reported by TechCrunch AI.
Read the full story at TechCrunch AI
AI & Automation · via TechCrunch AI
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
22h ago · curated by Catalyst Web Trendz
Put this to work
What it means for your brand.
Stories like this are exactly the terrain we work in every day. If this trend touches your growth plans, these are the services to look at:
More from the digest
Related headlines.
Agentic orchestration: Enterprise AI organizations have a deployment problem, not a platform problem — and most are calling chatbots agents
Across 101 enterprises, agent orchestration is consolidating onto model-provider platforms — Anthropic’s Claude leads by a wide margin — chosen for the gravity of the…
Read on our site
Amid hardware legal battle, OpenAI releases a $230 keyboard for Codex
OpenAI, which is in the middle of a legal battle with Apple over hardware trade theft allegations, just released a light-up keyboard designed to be paired with its…
Read on our site
SpaceX falls to $135 IPO price ahead of Starship launch
The stock has steadily fallen from the euphoric post-IPO high, showing that markets may be sobering up to the promises CEO Elon Musk made before and after SpaceX went…
Read on our site